About Medvic Formulations Private Limited
Data last updated:
Medvic Formulations Private Limited is a private limited company based in Greater Noida, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85300UP2018PTC103038. Its GSTIN is 09AALCM7634C1ZB (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Aradhana Srivastava and Karuneshkumar Shivmurthilal Shrivastav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 3T – 205 Rwa Awho Township Gurjinder Vihar Sector Chi 1 P – 5, Greater Noida, Uttar Pradesh, India – 201310.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.09 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹69,704 (net margin 0.2%) and EBITDA of ₹1 Lakh (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 234% over three years and 138% over five years.
For more details, the company can be reached via its website medvicformulations.com.
Company details
Contact details
Medvic Formulations Private Limited's registered office is in Greater Noida, Uttar Pradesh. Its website is medvicformulations.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No. 3T – 205 Rwa Awho Township Gurjinder Vihar Sector Chi 1 P – 5, Greater Noida, Uttar Pradesh, India – 201310
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medvic Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medvic Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medvic Formulations Private Limited, buy the company report.
Financials of Medvic Formulations Private Limited
FY 2025 filings availableMedvic Formulations Private Limited reported revenue of ₹4.09 Cr (up 2638% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 138% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹69,704 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medvic Formulations Private Limited, buy the company report.
Board of directors of Medvic Formulations Private Limited
Medvic Formulations has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aradhana Srivastava | Director | 11 Apr 2018 | 8 Years 6 Months | Current |
| Karuneshkumar Shivmurthilal Shrivastav Also directs: Karunchemy Enterprises Private Limited | Director | 11 Apr 2018 | 8 Years 6 Months | Current |
| Ashok Kumar Singh | Director | 02 Oct 2018 | 8 Years 1 Months | Current |
| Sulabh Saxena | Director | 17 Jan 2020 | 6 Years 9 Months | Current |
Auditor
Medvic Formulations Private Limited is audited by V YADAV & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V YADAV & ASSOCIATES | FY 2022 | 015004C |
Shareholding
The shareholding of Medvic Formulations Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Medvic Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medvic Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medvic Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medvic Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AALCM7634C1ZB | Uttar Pradesh | Active | 18 Mar 2020 |
To see the full GST registrations and return filing status of Medvic Formulations Private Limited, buy the company report.
Recent activity
Medvic Formulations Private Limited has 6 board changes on record since 2018: 4 appointments and 2 cessations. The latest: Sulabh Saxena was appointed as Director on 17 Jan 2020.
Frequently asked questions
Medvic Formulations is an active private limited company based in Greater Noida, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 April 2018 (8+ years old) and is registered under CIN U85300UP2018PTC103038.
Medvic Formulations has 4 current directors:
- Aradhana Srivastava - Director
- Karuneshkumar Shivmurthilal Shrivastav - Director
- Ashok Kumar Singh - Director
- Sulabh Saxena - Director
The latest financial statements of Medvic Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Medvic Formulations is 09AALCM7634C1ZB, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Medvic Formulations is U85300UP2018PTC103038. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medvic Formulations was incorporated on 11 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Sulabh Saxena was appointed as Director on 17 Jan 2020. Ashok Kumar Singh ceased to be Director on 06 Mar 2019. Ashok Kumar Singh was appointed as Director on 02 Oct 2018. Medvic Formulations has 6 board changes on record in total.
Medvic Formulations can be reached through the website medvicformulations.com. Its registered office is in Greater Noida, Uttar Pradesh, India.
The registered office of Medvic Formulations is at Flat No. 3T – 205 Rwa Awho Township Gurjinder Vihar Sector Chi 1 P – 5, Greater Noida, Uttar Pradesh, India – 201310.
Medvic Formulations operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
